Eversept Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Eversept Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-80,555	Closed	-$26.2M	–	86
2024 Q1	$26.2M	Buy	80,555 +4,733	+6%	+$1.16M	1.75%	16
2023 Q4	$14.4M	Sell	75,822 -8,640	-10%	-$1.63M	1.27%	20
2023 Q3	$16.8M	Buy	84,462 +64,324	+319%	+$15.2M	1.42%	18
2023 Q2	$5.75M	Sell	20,138 -27,439	-58%	-$7.62M	0.48%	39
2023 Q1	$10.3M	Buy	+47,577	New	+$9.27M	0.72%	30
2022 Q3	–	Sell	-3,300	Closed	-$631K	–	88
2022 Q2	$631K	Buy	+3,300	New	+$583K	0.04%	72

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Unique Wealth Strategies Burr Ridge, Illinois $273M AUM 19.98% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Eversept Partners's SWAV Position: Q2 2024 in Review

Eversept Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 80,555 shares — an estimated $26.2M sold.

Eversept Partners first reported a position in SWAV in Q2 2022 and held it in 6 quarters. The position peaked at $26.2M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Eversept Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Eversept Partners sold 80,555 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $26.2M.
Eversept Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Eversept Partners's Shockwave Medical, Inc. Common Stock position peaked at $26.2M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Eversept Partners's 13F filing for Q2 2024, filed 14 Aug 2024.